Lowered Plasma Copine 5 Levels Linked to Vascular Leakage and Mortality in Sepsis

Overview

This study identifies Copine 5 (CPNE5) as a novel biomarker predominantly expressed in aortic endothelial cells whose plasma levels are significantly reduced in sepsis patients. Reduced CPNE5 correlates with increased vascular leakage and higher mortality, findings validated in both human samples and a murine sepsis model.

Background

Sepsis is a life-threatening condition characterized by dysregulated host responses to infection, leading to organ dysfunction and high mortality rates in intensive care units. Endothelial barrier disruption and vascular leakage are key early events in sepsis pathophysiology, contributing to organ failure. While several vascular-associated biomarkers such as syndecan-1, angiopoietins, and soluble ICAM-1 have been studied, none have demonstrated sufficient predictive accuracy for sepsis outcomes. The Copine family of proteins, particularly CPNE5, has emerged as a potential regulator of endothelial function but its role in sepsis remains unexplored.

Data Highlights

Key Findings

• CPNE5 is uniquely and predominantly expressed in human aortic endothelial cells compared to other Copine family members.
• Sepsis patients exhibit significantly reduced plasma CPNE5 concentrations relative to healthy controls.
• Lower CPNE5 levels correlate with increased vascular permeability and higher mortality rates in sepsis.
• Knockdown of CPNE5 in endothelial cells increases vascular leakage, confirming its role in maintaining endothelial barrier integrity.
• Global CPNE5 knockout mice demonstrate exacerbated vascular hyperpermeability and worse outcomes in a murine sepsis model.

Clinical Implications

Measurement of plasma CPNE5 levels may serve as a sensitive and specific biomarker for early detection of vascular leakage and prognosis in sepsis patients. Therapeutic strategies aimed at restoring or preserving CPNE5 function could potentially improve endothelial barrier integrity and reduce sepsis-related mortality. Incorporating CPNE5 assessment alongside established biomarkers may enhance clinical decision-making in intensive care settings.

Conclusion

This study identifies CPNE5 as a critical regulator of endothelial barrier function whose decreased plasma levels are associated with vascular leakage and increased mortality in sepsis. CPNE5 holds promise as a novel prognostic biomarker and potential therapeutic target to improve sepsis outcomes.

References

1. Sepsis-3 Consensus (2016) -- Definition and clinical criteria for sepsis
2. Studies on endothelial biomarkers in sepsis (2010-2020)
3. Copine family protein functions and disease associations (2015-2023)
4. Single-nucleus RNA sequencing of human aorta (2021)